| Ivon Cabanas, | |
|
406 Se College Ave, Mcminnville, OR 97128-6407 | |
| (503) 932-4838 | |
| Not Available |
| Full Name | Ivon Cabanas |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 406 Se College Ave, Mcminnville, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063293843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ivon Cabanas, 406 Se College Ave, Mcminnville, OR 97128-6407 Ph: (503) 932-4838 | Ivon Cabanas, 406 Se College Ave, Mcminnville, OR 97128-6407 Ph: (503) 932-4838 |
News Archive
Noting the release of the Institute of Medicine's PEPFAR evaluation and "our own work-in-progress on PEPFAR's value for money and data management," Victoria Fan, a research fellow at the Center for Global Development (CGD), and Rachel Silverman, a research assistant at CGD, highlight "two focus areas that ... are the subject of a forthcoming CGD policy paper on PEPFAR's financial flows" in a post on CGD's "Global Health Policy" blog.
Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.
Researchers at the University of California, San Diego School of Medicine have documented the safety benefits of aortic stent grafts inserted during minimally invasive surgery to repair abdominal aortic aneurysms - weaknesses in the body's largest artery that can rupture, causing potentially lethal internal bleeding.
InControl Medical, LLC, a women's health company focusing on female urinary incontinence, has received FDA clearance for their proprietary, patented, InToneMV, providing women who suffer with vaginal atrophy a smaller, more comfortable medical device for the treatment of stress, urge and mixed female urinary incontinence without surgery or drugs.
› Verified 3 days ago
Lee J Monahan, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 627 Ne Evans St, Mcminnville, OR 97128 Phone: 503-434-7523 | |
Caitlin Briana Schrage, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 625 Ne Galloway St, Mcminnville, OR 97128 Phone: 503-434-7523 | |
Emily Broom, MA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 435 Ne Evans St Ste A, Mcminnville, OR 97128 Phone: 503-472-4020 Fax: 503-472-8630 | |
Kevin Brooks, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 627 Ne Evans St, Mcminnville, OR 97128 Phone: 503-434-7523 | |
Julie C. Siepmann, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1075 Se Cedarwood Ave, Mcminnville, OR 97128 Phone: 503-435-1550 | |
Kaitlyn Broock Brewer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Ne May Ln, Mcminnville, OR 97128 Phone: 503-472-1338 |